Molecular genetics, natural history and the demise of childhood leukaemia

European Journal of Cancer

Volumn 35, Issue 14, 1999, Pages 1941-1953

  Greaves, M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Aetiology; Apoptosis; Cancer cure; Chemotherapy; Differentiation; Foetus; Leukaemia; Pregnancy; Translocations; Twins

Indexed keywords

APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CHILD; CHILDHOOD LEUKEMIA; FUSION GENE; GENE MUTATION; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC DISORDER; GENETIC VARIABILITY; HUMAN; METASTASIS; MOLECULAR GENETICS; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0033372067     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00296-8     Document Type: Article

References (87)

1. Kersey J.H. Fifty years of studies of the biology and therapy of childhood leukemia. Blood. 90:1997;4243-4251.
2. Greaves M.F. Differentiation-linked leukaemogenesis in lymphocytes. Science. 234:1986;697-704.
3. Greaves M. The new biology of leukemia. In Henderson ES, Lister TA, Greaves MF, eds. Leukemia. Philadelphia, W B Saunders Company, 1996, 34-45.
4. Heisterkamp N., Stephenson J.R., Groffen J.et al. Localization of the c-abl oncogene adjacent to a translocation breakpoint in chronic myelocytic leukaemia. Nature. 306:1983;239-242.
5. Chan L.C., Karhi K.K., Rayter S.I.et al. A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia. Nature. 325:1987;635-637.
6. Secker-Walker L.M. Prognostic and biological importance of chromosome findings in acute lymphoblastic leukaemia. Cancer Genet. Cytogenet. 49:1990;1-13.
7. Greaves M.F. Stem cell origins of leukaemia and curability. Br. J. Cancer. 67:1993;413-423.
8. Hagemeijer A, Grosveld G. Molecular cytogenetics of leukemia. In Henderson ES, Lister TA, Greaves MF, eds. Leukemia. Philadelphia, W B Saunders, 1996, 131-144.
9. Rabbitts T.H. Chromosomal translocations in human cancer. Nature. 372:1994;143-149.
10. Look A.T. Oncogenic transcription factors in the human acute leukemias. Science. 278:1997;1059-1064.
11. Thirman M.J., Gill H.J., Burnett R.C.et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N. Engl. J. Med. 329:1993;909-914.
12. Mrozek K, Bloomfield CD. Major cytogenetic findings in non-Hodgkin's lymphoma. In Canellos GP, Lister TA, Sklar JL, eds. The Lymphomas. Philadelphia, W B Saunders, 1998, 107-128.
13. Greaves M.F. Workshop Report. Infant leukaemia biology, aetiology and treatment. Leukemia. 10:1996;372-377.
14. Raimondi S.C. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood. 81:1993;2237-2251.
15. Romana S.P., Poirel H., Leconiat M.et al. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood. 86:1995;4263-4269.
16. Secker-Walker L.M., Craig J.M., Hawkins J.M., Hoffbrand A.V. Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance. Leukemia. 5:1991;196-199.
17. Rowley J.D. Identification of the constant chromosome regions involved in human hematologic malignant disease. Science. 216:1982;749-750.
18. Greaves M. A natural history for pediatric acute leukemia. Blood. 82:1993;1043-1051.
19. Barr F.G. Translocations, cancer and the puzzle of specificity. Nature Genet. 19:1998;121-124.
20. Griffiths S.D., Healy L.E., Ford A.M.et al. Clonal characteristics of acute lymphoblastic cells derived from BCR/ABL p190 transgenic mice. Oncogene. 7:1992;1391-1399.
21. Corral J., Lavenir I., Impey H.et al. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell. 85:1996;853-861.
22. Enver T., Greaves M. Loops, lineage, and leukemia. Cell. 94:1998;9-12.
23. Taylor GM, Birch JM. The Hereditary Basis of Human Leukemia. In Henderson ES, Lister TA, Greaves MF, eds. Leukemia. Phildelphia, W B Saunders Company, 1996, 210-245.
24. Robison L.L., Nesbit M.E., Sather H.N.et al. Down syndrome and acute leukemia in children: a 10-year retrospective survey from Childrens Cancer Study Group. J. Pediatr. 105:1984;235-242.
25. Heim S., Bekassy A.N., Garwicz S.et al. New structural chromosomal rearrangements in congenital leukemia. Leukemia. 1:1987;16-23.
26. Ridge S.A., Cabrera M.E., Ford A.M.et al. Rapid intraclonal switch of lineage dominance in congenital leukaemia with a MLL gene rearrangement. Leukemia. 9:1995;2023-2026.
27. Hunger S.P., McGavran L., Meltesen L., Parker N.B., Kassenbrock C.K., Bitter M.A. Oncogenesis in utero fetal death due to acute myelogenous leukaemia with an MLL translocation. Br. J. Haematol. 103:1998;539-542.
28. Ross J.A., Davies S.M., Potter J.D., Robison L.L. Epidemiology of childhood leukemia, with a focus on infants. Epidemiol. Rev. 16:1994;243-272.
29. Smith M.A., Chen T., Simon R. Age-specific incidence of acute lymphoblastic leukemia in U.S. children: in utero initiation model. J. Natl. Cancer Inst. 89:1997;1542-1544.
30. Strong SJ, Corney G. The Placenta in Twin Pregnancy. Pergamon Press, Oxford, 1967.
31. Kumar D., Gemayel N.S., Deapen D.et al. North-American twins with IDDM. Genetic, etiological and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin. Diabetes. 42:1993;1351-1363.
32. Sadovnick A.D., Armstrong H., Rice G.P.A.et al. A population-based study of multiple sclerosis in twins: update. Ann. Neurol. 33:1993;281-285.
33. MacMahon B., Levy M.A. Prenatal origin of childhood leukemia. N. Engl. J. Med. 270:1964;1082-1085.
34. Danis R.P., Keith L.G. Some observations concerning leukemia in twins. Acta Genet. Med. Gemellol. 31:1982;173-177.
35. Clarkson B., Boyse E.A. Possible explanation of the high concordance for acute leukaemia in monozygous twins. Lancet. i:1971;699-701.
36. Ford A.M., Ridge S.A., Cabrera M.E.et al. In utero origin of rearrangements in the trithorax-related oncogene in infant leukaemias. Nature. 363:1993;358-360.
37. Gill Super H.J., Rothberg P.G., Kobayashi H., Freeman A.I., Diaz M.O., Rowley J.D. Clonal, nonconsitutional rearrangements of the MLL gene in infant twins with acute lymphoblastic leukemia: in utero chromosome rearrangement of 11q23. Blood. 83:1994;641-644.
38. Megonigal M.D., Rappaport E.F., Jones D.H.et al. t(11;22)(q23;q11.2) in acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes. Proc. Natl. Acad. Sci. USA. 95:1998;6413-6418.
39. Ford A.M., Pombo-de-Oliveira M.S., McCarthy K.P.et al. Monoclonal origin of concordant T-cell malignancy in identical twins. Blood. 89:1997;281-285.
40. Ford A.M., Bennett C.A., Price C.M., Bruin M.C.A., Van Wering E.R., Greaves M. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc. Natl. Acad. Sci. USA. 95:1998;4584-4588.
41. Wiemels JL, Ford AM, Van Wering ER, Postma A, Greaves M. Protracted and variable latency of acute lymphoblastic leukaemia after TEL-AML1 gene fusion in utero. Blood 1999, in press.
42. Wiemels J.L., Ford A.M., Bennett C.A.et al. Direct evidence for a pre-natal origin of TEL-AML1 gene fusions in paediatric leukaemia. Blood. 92(Suppl. 1):1998;68.
43. Jinks D.C., Minter M., Tarver D.A., Vanderford M., Hejtmancik J.F., McCabe E.R.B. Molecular genetic diagnosis of sickle cell disease using dried blood specimens on blotters used for newborn screening. Hum. Genet. 81:1989;363-366.
44. Raskin S., Phillips J.A., Kaplan G., McClure M., Vnencak-Jones C. Cystic fibrosis genotyping by direct PCR analysis of Guthrie blood spots. PCR Methods and Applications. 2:1992;154-156.
45. Comeau A.M., Hsu H-W., Schwerzler M.et al. Identifying human immunodeficiency virus infection at birth application of polymerase chain reaction to Guthrie cards. J. Pediatr. 123:1993;252-258.
46. Noda S., Eizuru Y., Minamishima Y., Ikenoue T., Mori N. Detection of human T-cell lymphotropic virus type 1 infection by the polymerase chain reaction using dried blood specimens on filter papers. J. Virol. Methods. 43:1993;111-122.
47. Gale K.B., Ford A.M., Repp R.et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc. Natl. Acad. Sci. USA. 94:1997;13950-13954.
48. Smith M.A., McCaffrey R.P., Karp J.E. The secondary leukemias: Challenges and research directions. J. Natl. Cancer Inst. 88:1996;407-418.
49. Romana S.P., Mauchauffe M., Le Coniat M.et al. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood. 85:1995;3662-3670.
50. Raynaud S., Cave H., Baens M.et al. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood. 87:1996;2891-2899.
51. Wang L.C., Swat W., Fujiwara Y.et al. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev. 12:1998;2392-2402.
52. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 84:1996;321-330.
53. Hiebert S.W., Sun W., Davis J.N.et al. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol. Cell. Biol. 16:1996;1349-1355.
54. McLean T.W., Ringold S., Neuberg D.et al. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood. 88:1996;4252-4258.
55. Greaves M.F., Alexander F.E. An infectious etiology for common acute lymphoblastic leukemia in childhood? Leukemia. 7:1993;349-360.
56. Kinlen L.J. Epidemiological evidence for an infective basis in childhood leukaemia. Br. J. Cancer. 71:1995;1-5.
57. Greaves M.F. Aetiology of acute leukaemia. Lancet. 349:1997;344-349.
58. MacKenzie J, Perry J, Ford AM, Jarrett RF, Greaves M. JC and BK virus sequences are not detectable in leukemic samples from children with common acute lymphoblastic leukemia. Br J Cancer 1999, in press.
59. Tsiagbe V.K., Yoshimoto T., Asakawa J., Cho S.Y., Meruelo D., Thorbecke G.J. Linkage of superantigen-like stimulation of syngeneic T cells in a mouse model of follicular center B cell lymphoma to transcription of endogenous mammary tumor virus. EMBO J. 12:1993;2313-2320.
60. Wotherspoon A.C., Doglioni C., Diss T.C.et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 342:1993;575-577.
61. Poynton F.J., Thursfield H., Paterson D. The severe blood diseases of childhood: a series of observations from the Hospital for Sick Children, Great Ormond Street. Br. J. Child. Dis. XIX:1922;128-144.
62. van Steensel-Moll H.A., Valkenburg H.A., van Zanen G.E. Childhood leukemia and infectious diseases in the first year of life a register-based case/control study. Am. J. Epidemiol. 124:1986;590-594.
63. Petridou E., Kassimos D., Kalmanti M.et al. Age of exposure to infections and risk of childhood leukaemia. Br. Med. J. 307:1993;774.
64. Shu X.O., Wen W., Buckley J., Brondum J., Linet M., Robison L. Lifestyle and risk of acute lymphocytic leukemia in children. Am. J. Epidemiol. 147(Suppl.):1998;37.
65. Tycko B., Sklar J. Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model. Cancer Cells. 2:1990;1-8.
66. Wiemels JL, Greaves MF. Genomic characterisation of the TEL-AML1 fusion in childhood acute lymphoblastic leukaemia. Cancer Res 1999, in press.
67. Zucman-Rossi J., Legoix P., Victor J-M., Lopez B., Thomas G. Chromosome translocation based on illegitimate recombination in human tumors. Proc. Natl. Acad. Sci. USA. 95:1998;11786-11791.
68. Groves FD, Linet MS, Devesa SS. Epidemiology of leukemia: overview and patterns of occurrence. In Henderson ES, Lister TA, Greaves MF, eds. Leukemia. Philadelphia, W B Saunders, 1996, 145-159.
69. Ross J.A., Potter J.D., Robison L.L. Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J. Natl. Cancer Inst. 86:1994;1678-1680.
70. Heerema N.A., Arthur D.C., Sather H.et al. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Children's Cancer Group. Blood. 83:1994;2274-2284.
71. Takeuchi S., Bartram C.R., Seriu T.et al. Analysis of a family of cyclin-dependent kinase inhibitors p15/MTS2/INK4B, p16/MTS1/INK4A, a p18 genes in acute lymphoblastic leukemia of childhood. Blood. 86:1995;755-760.
72. Rodenhuis S., Bos J.L., Slater R.M., Behrendt H., van't Veer M., Smets L.A. Absence of oncogene amplifications and occasional activation of N-ras in lymphoblastic leukemia of childhood. Blood. 67:1986;1698-1704.
73. Wada M., Bartram C.R., Nakamura H.et al. Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood. Blood. 82:1993;3163-3169.
74. Goga A., McLaughlin J., Afar D.E.H., Saffran D.C., Witte O.N. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene. Cell. 82:1995;981-988.
75. Kabarowski J.H.S, Allen P.B., Wiedemann L.M. A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells. EMBO J. 13:1994;5887-5895.
76. Harrington E., Fanidi A., Evan G. Oncogenes and cell death. Curr. Opin. Genet. Dev. 4:1994;120-129.
77. Kinzler K.W., Vogelstein B. Life (and death) in a malignant tumor. Nature. 379:1996;19-20.
78. Lowe S.W., Bodis S., McClatchey A.et al. p53 status and the efficacy of cancer therapy in vivo. Science. 266:1994;807-810.
79. Griffiths S.D., Clarke A.R., Healy L.E.et al. Absence of p53 permits propagation of mutant cells following genotoxic damage. Oncogene. 14:1997;523-531.
80. Griffiths S.D., Goodhead D.T., Marsden S.J.et al. Interleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis. J. Exp. Med. 179:1994;1789-1797.
81. Knudson A.G. Stem cell regulation, tissue ontogeny, and oncogenic events. Sem. Cancer Biol. 3:1992;99-106.
82. Fearon E., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
83. Hunter T., Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell. 79:1994;573-582.
84. Mack T.M., Cozen W., Shibata D.K.et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N. Engl. J. Med. 332:1995;413-418.
85. Zuelzer W.W., Cox D.E. Genetics aspects of leukemia. Sem. Hematol. 228:1969;228-249.
86. Buckley J.D., Buckley C.M., Breslow N.E., Draper G.J., Roberson P.K., Mack T.M. Concordance for childhood cancer in twins. Med. Pediatr. Oncol. 26:1996;223-229.
87. INK4a. Cell. 88:1997;593-602.